Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance
Janux, Vir Stocks Rally on Positive Data for Janux Drug JANX007
PTC Upgraded to Outperform by RBC on Novartis Deal
S&P 500 and Nasdaq Hit Closing and Trading Highs Monday | Wall Street Today
Merck & Co Unusual Options Activity For December 02
Gilead Sciences Ticks Upward for the Eight Consecutive Session
冰冰小 : To dispatch.
101877207 : Ok just received half hr ago
Johnson888 : Received 3.30pm today
Deep Sea : Tax rate on dividend is 30%.